CTLA-4-blocking immunotherapy with ipilimumab for advanced melanoma
- PMID: 21294474
CTLA-4-blocking immunotherapy with ipilimumab for advanced melanoma
Comment on
-
Ipilimumab: a promising immunotherapy for melanoma.Oncology (Williston Park). 2010 Dec;24(14):1280-8. Oncology (Williston Park). 2010. PMID: 21294471 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical